Table 2.
Strength of Provider Recommendation, Row% (n) |
p-value of vaccine recommendation compared to HPV** |
|||||
---|---|---|---|---|---|---|
Vaccine | Very Strongly | Somewhat Strongly | Not Very Strongly | Recommended AGAINST the Vaccine | Not Applicable – Vaccine was not Discussed | |
Tdap | 59% (202) | 24% (83) | 9% (29) | 0 | 8% (27) | <0.001 |
MCV | 45% (152) | 26% (88) | 12% (39) | 0 | 17% (58) | 0.011 |
Flu | 53% (181) | 29% (100) | 13% (46) | <1% (1) | 5% (17) | 0.004 |
HPV | 39% (133) | 34% (117) | 15% (53) | 1% (2) | 11% (38) | – |
*Skipped responses are excluded. Study occurred April 2014.
**Comparisons excluded those who indicated the vaccine was not discussed